Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

GM1-gangliosidosis: Accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types

  • 60 Accesses

  • 22 Citations

Summary

Uptake of radioactivity from 14C-galactose into gangliosides by cultured skin fibroblasts was studied. GM3 was the major ganglioside in control human fibroblasts. An increase of GM1 was demonstrated in GM1-gangliosidosis fibroblasts. The degree of GM1 accumulation was correlated with the clinical types of this disease. The fibroblasts from an infantile-type patient showed a marked increase of GM1. In late-onset types the amount of total gangliosides was only slightly increased, but the distribution of individual gangliosides was definitely abnormal; a relative increase of GM1 was demonstrated in these cases. GM1 β-galactosidase activities were not detectable in either infantile or late-onset cases.

This is a preview of subscription content, log in to check access.

References

  1. Cantz, M., Gehler, J., Spranger, J.: Mucolipidosis I: Increased sialic acid content and deficiency of an a-N-acetylneuraminidase in cultured fibroblasts. Biochem. Biophys. Res. Commun. 74, 732–738 (1977)

  2. Langenbach, R.: Gangliosides of chemically and virally transformed rat embryo cells. Biochim. Biophys. Acta 388, 231–242 (1975)

  3. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)

  4. Okada, S., O'Brien, J. S.: Generalized gangliosidosis. Beta-galactosidase deficiency. Science 160, 1002–1004 (1968)

  5. Porter, M. T., Fluharty, A. L., Trammell, J., Kihara, H.: A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy. Biochem. Biophys. Res. Commun. 44, 660–666 (1971)

  6. Strecker, G., Michalski, J. C., Montreuil, J., Farriaux, J. P.: Deficit in neuraminidase associated with mucolipidosis II (I-cell disease). Biomedicine 25, 238–239 (1976)

  7. Susuki, K.: The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, post-mortem changes and the effect of formalin preservation. J. Neurochem. 12, 629–638 (1965)

  8. Suzuki, Y., Fukuoka, K., Wey, J. J., Handa, S.: β-Galactosidase in mucopolysaccharidoses and mucolipidoses. Deficiency of GM1 β-galactosidase in liver and leukocytes. Clin. Chim. Acta 75, 91–97 (1977a)

  9. Suzuki, Y., Nakamura, N., Fukuoka, K., Shimada, Y., Uono, M.: β-Galactosidase deficiency in juvenile and adult patients. Report of six Japanese cases and review of literature. Hum. Genet. 36, 219–229 (1977b)

  10. Thomas, G. H., Tiller, Jr., G. E., Reynolds, L. W., Miller, C. S., Bace, J. W.: Increased levels of sialic acid associated with a sialidase deficiency in I-cell disease (mucolipidosis II) fibroblasts. Biochem. Biophys. Res. Commun. 71, 188–195 (1976)

  11. Yogeeswaran, G., Wherrett, J. R., Chatterjee, S., Murray, R. K.: Gangliosides of cultured mouse cells. Partial characterization and demonstration of 14C-glucosamine incorporation. J. Biol. Chem. 245, 6718–6725 (1970)

Download references

Author information

Correspondence to Yoshiyuki Suzuki.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Suzuki, Y., Nakamura, N. & Fukuoka, K. GM1-gangliosidosis: Accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types. Hum Genet 43, 127–131 (1978). https://doi.org/10.1007/BF00293589

Download citation

Keywords

  • Internal Medicine
  • Metabolic Disease
  • Relative Increase
  • Human Fibroblast
  • Skin Fibroblast